144th Day Of Lockdown

Maharashtra57273440144219427 Tamil Nadu3321052722515641 Andhra Pradesh2818171911172562 Karnataka2111081281823718 Delhi1519281351084178 Uttar Pradesh140775887862280 West Bengal98459671202059 Telangana9025966196684 Bihar8274154139450 Gujarat71064542382652 Assam5883842326145 Rajasthan5249738235789 Odisha4592731785321 Haryana4163534781483 Madhya Pradesh3902529020996 Kerala3811424922127 Jammu and Kashmir2489717003472 Punjab2390315319586 Jharkhand185168998177 Chhatisgarh12148880996 Uttarakhand96326134125 Goa871259575 Tripura6161417641 Puducherry5382320187 Manipur3752204411 Himachal Pradesh3371218114 Nagaland30119738 Arunachal Pradesh223115923 Chandigarh1595100425 Meghalaya11154986 Sikkim9105101 Mizoram6203230
Business Companies 01 Jul 2020 Patanjali coronil ge ...

Patanjali coronil gets AYUSH ministry nod, but not as COVID19 drug

Published Jul 1, 2020, 4:38 pm IST
Updated Jul 1, 2020, 4:38 pm IST
The Union ministry confirmed that Patanjali can sell the product but not as a cure for COVID-19
Representational image
 Representational image

Haridwar/New Delhi: Yoga guru Ramdev's Patanjali Ayurved on Wednesday said there are no AYUSH Ministry restrictions on selling Coronil, a drug the company recently launched as a medicine for COVID-19 but is now calling it a product to “manage” the disease.

The Union ministry confirmed that Patanjali can sell the product but not as a cure for COVID-19.


“AYUSH Ministry has only given permission to sell this particular formulation as immunity booster and not as a medicinal cure for COVID-19,” it said.

At a press conference in Haridwar, Ramdev claimed the ministry has said that Patanjali did an “an appropriate job for COVID-19 management”.

“I want to tell people who want to try these medicines that there is no restriction on their sale now and they will be available in a kit everywhere in the country from today," he added, referring to Coronil and the two other products Patanjali is promoting together.


Ramdev said the Union ministry had asked him to use the term “Covid management” in place of “Covid treatment” and he is following the instruction.

Even while backtracking on the describing Coronil as “treatment” for COVID-19, the company stuck to its claim that the drug's trial on mild to moderately ill patients was successful.

Its press note said the trial, conducted after the necessary approvals, showed 100 per cent recovery of patients within seven days.

It said the AYUSH Ministry has “categorically agreed” that Patanjali had “appropriately worked on COVID-19 management”.


“Now there is no difference of opinion between AYUSH Ministry and Patanjali,” it added.

“As per the ministry, Patanjali is allowed to manufacture and distribute its Diva Coronil tablet, Divya Swasari Vati and Divya Anu Talia across India, as per the manufacturing licences granted by State Licensing Authority, Ayurvedic and Unani Services, Govt of Uttarakhand,” it said.

The Uttarakhand department was among the agencies which had questioned Patanjali's claim to have developed a drug to cure COVID-19. It said the company had only been given a licence to manufacture an immunity booster.


Location: India, Uttarakhand, Haridwar